Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Julia Koerner"'
Autor:
Asma Ahmed, Cindy Reinhold, Eileen Breunig, Truong San Phan, Lea Dietrich, Feodora Kostadinova, Corinne Urwyler, Verena M. Merk, Mario Noti, Israel Toja da Silva, Konstantin Bode, Fatima Nahle, Anna Pia Plazzo, Julia Koerner, Regula Stuber, Constantin Menche, Eva Karamitopoulou, Henner F. Farin, Kenneth J. Gollob, Thomas Brunner
Publikováno v:
Molecular Oncology, Vol 17, Iss 8, Pp 1545-1566 (2023)
Control of tumour development and growth by the immune system critically defines patient fate and survival. What regulates the escape of colorectal tumours from destruction by the immune system remains currently unclear. Here, we investigated the rol
Externí odkaz:
https://doaj.org/article/e2887ae1833f4172bd9bbea51ee70193
Publikováno v:
OncoImmunology, Vol 12, Iss 1 (2023)
ABSTRACTNew treatment options to battle hormone-refractory prostate carcinoma (PC) are a pressing medical need. Chronic inflammation has been implicated in PC etiology. The pro-inflammatory cytokines IL-6, IL-23 and IL-17 are key mediators to promote
Externí odkaz:
https://doaj.org/article/cc7d291fe74c4869aaf5b9f40ceb7cde
Autor:
Julia Koerner, Dennis Horvath, Valerie L. Herrmann, Anna MacKerracher, Bruno Gander, Hideo Yagita, Jacques Rohayem, Marcus Groettrup
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-16 (2021)
PLGA based cancer immunotherapy incorporating antigen and TLR ligands has resulted in enhancement of the anti-tumour response. Here, the authors explore the use of a defined double stranded RNA adjuvant, Riboxxim, and test its incorporation with PLGA
Externí odkaz:
https://doaj.org/article/49f713706d4f4e6c84d91492aa8a5fb5
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
With emerging success in fighting off cancer, chronic infections, and autoimmune diseases, immunotherapy has become a promising therapeutic approach compared to conventional therapies such as surgery, chemotherapy, radiation therapy, or immunosuppres
Externí odkaz:
https://doaj.org/article/4ee1f81df9934f9282dba639927d363e
Publikováno v:
OncoImmunology. 12
New treatment options to battle hormone-refractory prostate carcinoma (PC) are a pressing medical need. Chronic inflammation has been implicated in PC etiology. The pro-inflammatory cytokines IL-6, IL-23 and IL-17 are key mediators to promote growth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b5409ecd96d8a0fcd4bcb1152256ab3
https://doi.org/10.1080/2162402x.2022.2156091
https://doi.org/10.1080/2162402x.2022.2156091
Autor:
Tyson Keen Phillips, Michael Pickoff, Nichole Tortorici, Kyoung Eun Park, Julia Koerner-Al-Rawi
Publikováno v:
Construction Robotics. 4:175-185
This paper presents an efficient workflow for the established digital fabrication and robotic assembly of a discrete timber structure. Here, the complexity and aesthetic value of the structure are derived from the aggregation and assembly of similar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::94d92633bc5760bc7201e2692aa1f0d3
https://doi.org/10.1007/s41693-020-00045-6
https://doi.org/10.1007/s41693-020-00045-6
Publikováno v:
Kidney International. 95:611-623
Chronic antibody-mediated rejection is the leading cause of allograft dysfunction and loss after kidney transplantation, and current immunosuppressive regimens fail to target the plasma cells that produce alloantibodies. We previously showed that tre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e91e80a4c38fdf7ac6a88e6be0be97d
https://doi.org/10.1016/j.kint.2018.10.022
https://doi.org/10.1016/j.kint.2018.10.022
Autor:
Dennis Horvath, Valerie Laura Herrmann, Hideo Yagita, Anna MacKerracher, Julia Koerner, Marcus Groettrup, Bruno Gander, Jacques Rohayem
Publikováno v:
Nature Communications
Nature Communications, Vol 12, Iss 1, Pp 1-16 (2021)
Nature Communications, 12 (1)
Nature Communications, Vol 12, Iss 1, Pp 1-16 (2021)
Nature Communications, 12 (1)
With emerging supremacy, cancer immunotherapy has evolved as a promising therapeutic modality compared to conventional antitumor therapies. Cancer immunotherapy composed of biodegradable poly(lactic-co-glycolic acid) (PLGA) particles containing antig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89708e7345e8e595e472959b40f2cf07
Autor:
Elmer Maurits, Herman S. Overkleeft, Marcus Groettrup, Michael Basler, Julia Koerner, Gerjan de Bruin
Publikováno v:
British Journal of Pharmacology. 175:38-52
Background and Purpose Multicatalytic endopeptidase complex-like-1 (β2i), low molecular mass polypeptide (LMP) 2 (β1i) and LMP7 (β5i) are the proteolytically active subunits of the immunoproteasome, a special type of proteasome mainly expressed in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ec434ebaa26b790834de136ebab7d2cd
https://doi.org/10.1111/bph.14069
https://doi.org/10.1111/bph.14069